Surgery for keratoconus and corneal ectasia
Part of Eyes & vision clinical trials.
This trial tests a surgery called CTAK for people with keratoconus or corneal ectasia. It aims to see if the surgery can help improve vision by reshaping the cornea.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have keratoconus or corneal ectasia (a condition where the cornea becomes thin and bulges out).
- Your cornea cannot be too thin for the surgery.
- You cannot have significant scarring on your cornea.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests how safe and well a corneal cross-linking device (called PXL-Platinum 330) works for people with corneal ectasia (a thinning/steepening of the cornea). If you qualify, the goal is to help stop or slow further worsening of your cornea shape and improve eye stability.
This trial uses special eye imaging to measure how your cornea (the eye’s clear front surface) changes, and then builds a personalized model for you. It may help doctors plan safer, more tailored treatment for keratoconus—especially if you’re considering LASIK.
This study looks at people with corneal disease, especially corneal thinning that can change how the eye focuses light. It may help researchers understand treatments and care plans for these conditions.
This trial tests two different laser-based procedures to treat keratoconus, a condition that weakens and bulges the cornea. The goal is to see which approach better strengthens the eye and improves vision.
This study looks at how donor corneas (for deep lamellar corneal transplant in keratoconus) are prepared using corneal collagen cross-linking, to see if it improves outcomes for people with keratoconus. You may be eligible if you meet vision and cornea shape/thickness requirements and can return for long follow-up.
This study tests whether a special eye scan called OCT can better identify causes of irregular cornea shape. Results may help doctors sort out different cornea problems so treatment choices, like certain procedures, can be more targeted.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.